Akutes Lungenversagen (ARDS)

Das akute Lungenversagen des Erwachsenen (acute respiratory distress syndrome, ARDS) ist ein multifaktorielles Geschehen und für den Intensivmediziner eine häufige Herausforderung mit nach wie vor hoher Mortalität [1]. Viele neue Therapiekonzepte, auch die extrakorporale Membranoxygenierung (ECMO), bleiben bisher ohne sicheren Nachweis eines verbesserten Outcomes. In dieser Übersichtsarbeit werden die wesentlichen Aussagen der 2017 erschienenen S3-Leitlinie [2] dargestellt.

Schlüsselwörter

ARDS - Beatmung - Intensivmedizin - extrakorporale Membranoxygenierung

• Literatur

• 1 Bellani G, Laffey JG, Pham T. et al. Epidemiology, Patterns of Care, and Mortality for Patients With Acute Respiratory Distress Syndrome in Intensive Care Units in 50 Countries. JAMA 2016; 315: 788-800 doi:10.1001/jama.2016.0291
• 2 Adamzik M, Bauer A, Bein T. S3-Leitlinie Invasive Beatmung und Einsatz extrakorporaler Verfahren bei akuter respiratorischer Insuffizienz. AWMF Leitlinien-Register Nr. 001/021 (2017). Im Internet: https://www.awmf.org/uploads/tx_szleitlinien/001-021k_S3_Invasive_Beatmung_2017-12.pdf Stand: 05.12.2017
• 3 Ashbaugh DG, Bigelow DB, Petty TL. et al. Acute respiratory distress in adults. Lancet 1967; 2: 319-323
• 4 Murray JF, Matthay MA, Luce JM. et al. An expanded definition of the adult respiratory distress syndrome. Am Rev Respir Dis 1988; 138: 720-723
• 5 Force ADT, Ranieri VM, Rubenfeld GD. et al. Acute respiratory distress syndrome: the Berlin Definition. JAMA 2012; 307: 2526-2533 doi:10.1001/jama.2012.5669
• 6 Pham T, Rubenfeld GD. Fifty Years of Research in ARDS. The Epidemiology of Acute Respiratory Distress Syndrome. A 50th Birthday Review. Am J Respir Crit Care Med 2017; 195: 860-870 doi:10.1164/rccm.201609-1773CP
• 7 Garcia-Laorden MI, Lorente JA, Flores C. et al. Biomarkers for the acute respiratory distress syndrome: how to make the diagnosis more precise. Ann Transl Med 2017; 5: 283 doi:10.21037/atm.2017.06.49
• 8 Calfee CS, Ware LB, Eisner MD. et al. Plasma receptor for advanced glycation end products and clinical outcomes in acute lung injury. Thorax 2008; 63: 1083-1089 doi:10.1136/thx.2008.095588
• 9 Jabaudon M, Blondonnet R, Pereira B. et al. Plasma sRAGE is independently associated with increased mortality in ARDS: a meta-analysis of individual patient data. Intensive Care Med 2018; 44: 1388-1399 doi:10.1007/s00134-018-5327-1
• 10 Agrawal A, Matthay MA, Kangelaris KN. et al. Plasma angiopoietin-2 predicts the onset of acute lung injury in critically ill patients. Am J Respir Crit Care Med 2013; 187: 736-742 doi:10.1164/rccm.201208-1460OC
• 11 Terpstra ML, Aman J, van Nieuw Amerongen GP. et al. Plasma biomarkers for acute respiratory distress syndrome: a systematic review and meta-analysis*. Crit Care Med 2014; 42: 691-700 doi:10.1097/01.ccm.0000435669.60811.24
• 12 Weg JG, Anzueto A, Balk RA. et al. The relation of pneumothorax and other air leaks to mortality in the acute respiratory distress syndrome. N Engl J Med 1998; 338: 341-346 doi:10.1056/NEJM199802053380601
• 13 Amato MB, Meade MO, Slutsky AS. et al. Driving pressure and survival in the acute respiratory distress syndrome. N Engl J Med 2015; 372: 747-755 doi:10.1056/NEJMsa1410639
• 14 Grieco DL, Chen L, Brochard L. Transpulmonary pressure: importance and limits. Ann Transl Med 2017; 5: 285 doi:10.21037/atm.2017.07.22
• 15 Meade MO, Cook DJ, Guyatt GH. et al. Ventilation strategy using low tidal volumes, recruitment maneuvers, and high positive end-expiratory pressure for acute lung injury and acute respiratory distress syndrome: a randomized controlled trial. JAMA 2008; 299: 637-645 doi:10.1001/jama.299.6.637
• 16 Cavalcanti AB, Suzumura EA. et al. Writing Group for the Alveolar Recruitment for Acute Respiratory Distress Syndrome Trial I. Effect of Lung Recruitment and Titrated Positive End-Expiratory Pressure (PEEP) vs. Low PEEP on Mortality in Patients With Acute Respiratory Distress Syndrome: A Randomized Clinical Trial. JAMA 2017; 318: 1335-1345 doi:10.1001/jama.2017.14171
• 17 Forel JM, Roch A, Marin V. et al. Neuromuscular blocking agents decrease inflammatory response in patients presenting with acute respiratory distress syndrome. Crit Care Med 2006; 34: 2749-2757 doi:10.1097/01.CCM.0000239435.87433.0D
• 18 Gainnier M, Roch A, Forel JM. et al. Effect of neuromuscular blocking agents on gas exchange in patients presenting with acute respiratory distress syndrome. Crit Care Med 2004; 32: 113-119 doi:10.1097/01.CCM.0000104114.72614.BC
• 19 Papazian L, Forel JM, Gacouin A. et al. Neuromuscular blockers in early acute respiratory distress syndrome. N Engl J Med 2010; 363: 1107-1116 doi:10.1056/NEJMoa1005372
• 20 Kallet RH. A Comprehensive Review of Prone Position in ARDS. Respir Care 2015; 60: 1660-1687 doi:10.4187/respcare.04271
• 21 Charron C, Bouferrache K, Caille V. et al. Routine prone positioning in patients with severe ARDS: feasibility and impact on prognosis. Intensive Care Med 2011; 37: 785-790 doi:10.1007/s00134-011-2180-x
• 22 Guerin C, Reignier J, Richard JC. et al. Prone positioning in severe acute respiratory distress syndrome. N Engl J Med 2013; 368: 2159-2168 doi:10.1056/NEJMoa1214103
• 23 Guerin C, Beuret P, Constantin JM. et al. A prospective international observational prevalence study on prone positioning of ARDS patients: the APRONET (ARDS Prone Position Network) study. Intensive Care Med 2018; 44: 22-37 doi:10.1007/s00134-017-4996-5
• 24 Humphrey H, Hall J, Sznajder I. et al. Improved survival in ARDS patients associated with a reduction in pulmonary capillary wedge pressure. Chest 1990; 97: 1176-1180
• 25 National Heart, Lung, and Blood Institute Acute Respiratory Distress Syndrome (ARDS) Clinical Trials Network, Wiedemann HP, Wheeler AP, Bernard GR. . et al. Comparison of two fluid-management strategies in acute lung injury. N Engl J Med 2006; 354: 2564-2575 doi:10.1056/NEJMoa062200
• 26 Gao Smith F, Perkins GD, Gates S. et al. Effect of intravenous beta-2 agonist treatment on clinical outcomes in acute respiratory distress syndrome (BALTI-2): a multicentre, randomised controlled trial. Lancet 2012; 379: 229-235 doi:10.1016/S0140-6736(11)61623-1
• 27 McAuley DF, Laffey JG, OʼKane CM. et al. Simvastatin in the Acute Respiratory Distress Syndrome. N Engl J Med 2014; 371: 1695-1703
• 28 Meduri GU, Bridges L, Shih MC. et al. Prolonged glucocorticoid treatment is associated with improved ARDS outcomes: analysis of individual patientsʼ data from four randomized trials and trial-level meta-analysis of the updated literature. Intensive Care Med 2016; 42: 829-840 doi:10.1007/s00134-015-4095-4
• 29 Steinberg KP, Hudson LD, Goodman RB. et al. Efficacy and safety of corticosteroids for persistent acute respiratory distress syndrome. N Engl J Med 2006; 354: 1671-1684 doi:10.1056/NEJMoa051693
• 30 Karagiannidis C, Windisch W. Epidemiologie und Mortalität der Herz- und Lungenersatzverfahren in Deutschland zwischen 2007 und 2014. Med Klin Intensivmed Notfmed 2016; 111: 556-559 doi:10.1007/s00063-016-0207-3
• 31 Peek GJ, Mugford M, Tiruvoipati R. et al. Efficacy and economic assessment of conventional ventilatory support versus extracorporeal membrane oxygenation for severe adult respiratory failure (CESAR): a multicentre randomised controlled trial. Lancet 2009; 374: 1351-1363 doi:10.1016/S0140-6736(09)61069-2
• 32 Combes A, Hajage D, Capellier G. et al. Extracorporeal membrane oxygenation for severe acute respiratory distress syndrome. N Engl J Med 2018; 378: 1965-1975 doi:10.1056/NEJMoa1800385
• 33 Gattinoni L, Vasques F, Quintel M. Use of ECMO in ARDS: does the EOLIA trial really help?. Crit Care 2018; 22: 171 doi:10.1186/s13054-018-2098-6
• 34 Hébert PC, Wells G, Blajchman MA. et al. A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. Transfusion Requirements in Critical Care Investigators, Canadian Critical Care Trials Group. N Engl J Med 1999; 340: 409-417 doi:10.1056/NEJM199902113400601
• 35 Holst LB, Haase N, Wetterslev J. et al. Lower versus higher hemoglobin threshold for transfusion in septic shock. N Engl J Med 2014; 371: 1381-1391 doi:10.1056/NEJMoa1406617
• 36 Engoren M. The effect of red blood cell transfusion on 90-day mortality in patients with acute lung injury. J Intensive Care Med 2012; 27: 112-118 doi:10.1177/0885066610394326
• 37 Agerstrand CL, Burkart KM, Abrams DC. et al. Blood conservation in extracorporeal membrane oxygenation for acute respiratory distress syndrome. Ann Thorac Surg 2015; 99: 590-595 doi:10.1016/j.athoracsur.2014.08.039
• 38 Voelker MT, Busch T, Bercker S. et al. Restrictive transfusion practice during extracorporeal membrane oxygenation therapy for severe acute respiratory distress syndrome. Artif Organs 2015; 39: 374-378 doi:10.1111/aor.12385
• 39 Boissier F, Katsahian S, Razazi K. et al. Prevalence and prognosis of cor pulmonale during protective ventilation for acute respiratory distress syndrome. Intensive Care Med 2013; 39: 1725-1733 doi:10.1007/s00134-013-2941-9
• 40 Lotz C, Roewer N, Muellenbach RM. Organersatzverfahren – Kreislaufunterstützung und -ersatz. Anästhesiol Intensivmed Notfallmed Schmerzther 2016; 51: 564-572 doi:10.1055/s-0041-109831
• 41 Gebistorf F, Karam O, Wetterslev J. et al. Inhaled nitric oxide for acute respiratory distress syndrome (ARDS) in children and adults. Cochrane Database Syst Rev 2016; (06) CD002787
• 42 Bhorade S, Christenson J, OʼConnor M. et al. Response to inhaled nitric oxide in patients with acute right heart syndrome. Am J Respir Crit Care Med 1999; 159: 571-579 doi:10.1164/ajrccm.159.2.9804127